31 May 2022 - Compared with nine other European countries, Switzerland remains a high-price island for medicines, according to an annual survey by health insurer body santésuisse and pharma research group Interpharma.
The price difference was again most marked for generic drugs – i.e. mass-produced copies of established products, the groups said on Tuesday.